Assunto: CARCINOMA HEPATOCELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELIZÁRIO, Jose Ernesto e MALPARTIDA, Humberto Miguel Garay. Key epigenetic players in etiology and novel combinatorial therapies for treatment of hepatocellular carcinoma. Livers, v. 4, n. 4, p. 638–655, 2024Tradução . . Disponível em: http://dx.doi.org/10.3390/livers4040044. Acesso em: 22 jan. 2026.APA
Belizário, J. E., & Malpartida, H. M. G. (2024). Key epigenetic players in etiology and novel combinatorial therapies for treatment of hepatocellular carcinoma. Livers, 4( 4), 638–655. doi:10.3390/livers4040044NLM
Belizário JE, Malpartida HMG. Key epigenetic players in etiology and novel combinatorial therapies for treatment of hepatocellular carcinoma [Internet]. Livers. 2024 ; 4( 4): 638–655.[citado 2026 jan. 22 ] Available from: http://dx.doi.org/10.3390/livers4040044Vancouver
Belizário JE, Malpartida HMG. Key epigenetic players in etiology and novel combinatorial therapies for treatment of hepatocellular carcinoma [Internet]. Livers. 2024 ; 4( 4): 638–655.[citado 2026 jan. 22 ] Available from: http://dx.doi.org/10.3390/livers4040044
